BioSpace News Archive

Positive Phase 3 Study Results for TRIKAFTA ® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older With Cystic Fibrosis Who Have One Copy of the F508del Mutation and One Gating or Residual Function Mutation -Phase 3 study met primary endpoint and all secondary endpoints- -Study is a U.S. post-marketing commitment and will be submitted to FDA- -Data also will be submitted to the European Medicines Agency to support indic

PerkinElmer Introduces AuroFlow ® AQ Mycotoxin Platform to Support Testing for Top Six Regulated Mycotoxins in Grain Commodities Features water-based testing strips and handheld reader delivering convenience and accuracy

Vitro Diagnostics, Inc.. (OTC PINK:VODG), dba Vitro Biopharma, announced that it has engaged MaloneBailey L.L.P. (Certified Public Accounting Firm www.malonebailey.com ) as its new auditors that will be auditing the company’s consolidated balance sheets as of October 31, 2019 and October 31, 2020

Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, is pleased to announce the appointment of Mr. John Brancaccio to its Board as a Non-executive Director. Mr. Brancaccio, retired CPA, is a financial executive with extensive international and domestic experience in pharmaceutical and biote

ivWatch, LLC, provider of continuous monitoring devices focused on improving patient safety and the effectiveness of intravenous (IV) therapy, today announced the issuance of two new patents in Japan and Australia, increasing the company’s patent portfolio to 31. ivWatch patented technology works in partnership with clinicians to reduce the harm

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that health insurance coverage of more than 50 million lives were added for the Sonata® treatment within the first 6 months of 2020.

Ag-West Bio Inc. welcomes four new members to its board of directors. Erin Armstrong (Barley Council of Canada), Drew Britz (Saskatoon Airport Authority (retired)), Shannon Hood-Niefer (Saskatchewan Food Industry Development Centre), and Chris Masich (McKercher LLP) were voted in at the June 2020 annual meeting of members.

Athersys, Inc. will release its second quarter 2020 financial results at approximately 4:00 PM Eastern Time on Monday, August 10, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.

In continuing its implementation of a fully comprehensive and integrated kidney care model, Dialyze Direct, the largest staff-assisted home dialysis provider in nursing facilities, announced today their strategic partnership with NANI (Nephrology Associates of Northern Illinois and Indiana), which is focused on improving patient care for those receiving dialysis treatments.

Philadelphia College of Osteopathic Medicine announced it will receive a $5 million gift, the largest in the College’s 121-year history, from Howard A. Hassman, DO ’83.